Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiologyheart failure, electrophysiologyhypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

INVOKANA® (canagliflozin) Demonstrated Significant Renal Protective Benefits in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease

AUSTIN, Texas, April 12, 2018 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced an additional analysis from the landmark CANVAS Program showing INVOKANA® (canagliflozin) improved renal outcomes in people with type 2 diabetes mellitus with or at high risk for cardiovascular disease.

Thumbnail

Insurance plans denied coverage for almost 80K claims for cholesterol-lowering drugs

A report issued by the Institute for Patient Access suggests commercial healthcare insurance plans, as well as Medicare, Medicaid and Medicaid managed care, denied coverage for almost 80,000 insurance claims for PCSK9 inhibitors in 2017.

Thumbnail

More employers are engaging in weight loss programs to increase productivity

To mitigate the obesity epidemic, increase workplace productivity and reduce absences, employers across the United States are engaging in employee-wide wellness programs.

Thumbnail

Elevated pre-pregnancy blood pressure may increase risk for miscarriage

Elevated blood pressure before pregnancy may increase the risk for miscarriage, according to findings published April 2 in Hypertension. This proves true for women who exhibit high blood pressure preconception but have not been diagnosed with hypertension.

Severity of menopausal symptoms correlated to vascular complications, aging

There is no timetable for menopause—with perimenopausal symptoms often appearing in a woman’s mid-40s and lasting an average of four years before menstruation ends. These changes affect much more than the reproductive system, with recent research finding the severity of symptoms is tied to vascular aging and other complications.

Thumbnail

Wildfire smoke may cause spike in CVD events

Smoke from wildfires may trigger heart- and stroke-related events, particularly among seniors, suggests data from the 2015 California wildfire season published in the Journal of the American Heart Association.

Thumbnail

Biochemist: Omega-3 fatty acids may reduce CVD risk—but loosely regulated supplements muddy the picture

Fish oil supplements shouldn’t be considered equivalent to omega-3 products that have undergone strict clinical testing and FDA oversight, said biochemist Preston Mason, PhD. The first group of products could be harmful to patients with cardiovascular disease, while more refined compounds might help.

Thumbnail

Researchers: Online ICD message board littered with inaccuracies

Only half of medical advice on an online message board dedicated to implanted cardiac defibrillators (ICDs) appears to be accurate, according to preliminary research presented April 7 at the American Heart Association’s Quality of Care and Outcomes Research Scientific Sessions 2018.